Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity. - Zimmerman O; Altman Doss AM; Ying B; Liang CY; Mackin SR; Davis-Adams HG; Adams LJ; VanBlargan LA; Chen RE; Scheaffer SM; Desai P; Raju S; et al. (JCI insight, 2024)